Postmarket Safety Actions for Novel Oncology Drugs Granted FDA's Accelerated Approval.

ABSTRACT:

SUBMITTER: Mooghali M 

PROVIDER: S-EPMC12801081 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature